Postoperative histopathology confirmed a moderately differentiated neoplasm comprising both squamous cell carcinoma and adenocarcinoma components, accompanied by immunohistochemical loss of PMS2 and MLH-1 expression, alongside MLH-1 gene methylation. This evidence concerns the gene MLH1 and squamous cell carcinoma.